EUVIMEDScopri EUVIMED
Crossref

Prognostic Significance of the Detection of Human Papilloma Virus L1 Protein in Smears of Cervical Intraepithelial Neoplasia Grade 3 in Pregnant Women

Frederik A Stuebs, Anna K Dietl, Carla E Schulmeyer, Annika S Behrens, Anja Seibold, Lena Brueckner, Oliver Schleicher, Werner Adler, Carol Geppert, Arndt Hartman, Antje Knöll, Matthias W Beckmann and 3 more

Anticancer Research · 2025

DOI: 10.21873/anticanres.17455 ↗

At a glance

Journal article in Anticancer Research, 2025. Written by Frederik A Stuebs and 14 co-authors. Institution: Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Friedrich Alexander Uni…. Major MEDLINE topics: Uterine Cervical Dysplasia, Capsid Proteins, Uterine Cervical Neoplasms, Oncogene Proteins, Viral.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

BACKGROUND/AIM: Cervical intraepithelial neoplasia (CIN) III/high-grade squamous lesions (HSIL) remains a significant challenge during pregnancy. Current data on the course of disease are contradictory, with cases of progression to cervical cancer (CC) during pregnancy being observed. Evidence suggests that the expression of L1 capsid protein is associated with a favorable prognosis in non-pregnant women. The aim of this study was to evaluate L1 expression in pregnant women with CIN III/HSIL. PATIENTS AND METHODS: Between 2008 and 2021, the conventional PAP-smears from pregnant women were retrospectively analyzed for the expression of L1. Only women with histologically confirmed CIN III/HSIL during pregnancy were included. RESULTS: A total of 161 women were included in this study; among them, 32 women (19.9%) had regressive disease postpartum. The majority of women (n=123, 76.4%) had persistent disease. In six cases, invasive CC was histologically proven postpartum (3.7%). In 113 women (70.2%) the PAP-Smears were L1- and 29.2% (n=48) of women were L1+. The rates of regression for L1+ were higher than for L1-, 25% vs. 17.7%, respectively. Rates for persistence were similar, at 75% and 78%, respectively. All cases of progression to CC were L1 negative during pregnancy. CONCLUSION: In pregnant women, the rates of regression were higher in L1+ CIN III/HSIL cases. All women who progressed to CC were L1-. Therefore, detecting L1 expression could serve as a valuable test to rule out progression to CC in pregnant women. This approach may provide reassurance to women, allowing them to continue their pregnancies with reduced fear and anxiety about CIN III/HSIL during pregnancy.

Subjects

MeSH terms (MEDLINE)

Uterine Cervical DysplasiaCapsid ProteinsUterine Cervical NeoplasmsOncogene Proteins, ViralPregnancy Complications, NeoplasticPapillomavirus InfectionsHumansFemalePregnancyAdultPrognosisRetrospective StudiesVaginal SmearsPapanicolaou TestYoung AdultNeoplasm GradingHuman Papillomavirus Viruses

Author keywords

CIN III/HSILColposcopyL1 capsid proteincervical cancerpregnancy

Substances

Capsid ProteinsHPV L1 protein, Human papillomavirusOncogene Proteins, Viral

Authors and institutions

  • Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany frederik.stuebs@uk-er…
  • Bavarian Cancer Research Center (BZKF), Erlangen, Germany.
  • Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany.
  • Department of Medical Informatics, Biometry and Epidemiology, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany.
  • Institute of Pathology, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Erlangen, Germany.
  • Institute of Clinical and Molecular Virology, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Erlangen, Germany.

Cite

APA

Stuebs, F. A., Dietl, A. K., Schulmeyer, C. E., Behrens, A. S., Seibold, A., Brueckner, L., Schleicher, O., Adler, W., Geppert, C., Hartman, A., Knöll, A., Beckmann, M. W., Gass, P., Hilfrich, R., & Mehlhorn, G. (2025). Prognostic Significance of the Detection of Human Papilloma Virus L1 Protein in Smears of Cervical Intraepithelial Neoplasia Grade 3 in Pregnant Women. Anticancer Research. https://doi.org/10.21873/anticanres.17455

Vancouver

Stuebs FA, Dietl AK, Schulmeyer CE, Behrens AS, Seibold A, Brueckner L, et al. Prognostic Significance of the Detection of Human Papilloma Virus L1 Protein in Smears of Cervical Intraepithelial Neoplasia Grade 3 in Pregnant Women. Anticancer Research. 2025. doi:10.21873/anticanres.17455

BibTeX
@article{Stuebs2025,
  author = {Stuebs, Frederik A and Dietl, Anna K and Schulmeyer, Carla E and Behrens, Annika S and Seibold, Anja and Brueckner, Lena and Schleicher, Oliver and Adler, Werner and Geppert, Carol and Hartman, Arndt and Knöll, Antje and Beckmann, Matthias W and Gass, Paul and Hilfrich, Ralf and Mehlhorn, Grit},
  title = {Prognostic Significance of the Detection of Human Papilloma Virus L1 Protein in Smears of Cervical Intraepithelial Neoplasia Grade 3 in Pregnant Women},
  journal = {Anticancer Research},
  year = {2025},
  doi = {10.21873/anticanres.17455}
}
Start for free →